{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:31:14Z","timestamp":1770816674160,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 DK104721"],"award-info":[{"award-number":["T32 DK104721"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR001429"],"award-info":[{"award-number":["KL2 TR001429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>We used electronic health records (EHRs) data from 5658 ambulatory chronic kidney disease (CKD) patients with hypertension and prescribed antihypertensive therapy to examine antihypertensive drug prescribing patterns, blood pressure (BP) control, and risk factors for resistant hypertension (RHTN) in a real\u2010world setting. Two\u2010thirds of CKD patients and three\u2010fourths of those with proteinuria were prescribed guideline\u2010recommended renoprotective agents including an angiotensin\u2010converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB); however, one\u2010third were not prescribed an ACEI or ARB. CKD patients, particularly those with stages 1\u20102 CKD, who were prescribed regimens including beta\u2010blocker (BB)\u00a0+\u00a0diuretic or ACEI\/ARB\u00a0+\u00a0BB\u00a0+\u00a0diuretic were more likely to have controlled BP (&lt;140\/90\u00a0mm\u00a0Hg) compared to those prescribed other combinations. Risk factors for RHTN included African American race and major comorbidities. Clinicians may use these findings to tailor antihypertensive therapy to the needs of each patient, including providing CKD stage\u2010specific treatment, and better identify CKD patients at risk of RHTN.<\/jats:p>","DOI":"10.1111\/jch.13429","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T10:54:54Z","timestamp":1542192894000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease"],"prefix":"10.1111","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-9157","authenticated-orcid":false,"given":"Oyunbileg","family":"Magvanjav","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda M.","family":"Cooper\u2010DeHoff","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Gainesville Florida"},{"name":"Division of Cardiovascular Medicine, Department of Medicine University of Florida College of Medicine Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitrin W.","family":"McDonough","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-1620","authenticated-orcid":false,"given":"Yan","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Segal","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension and Renal Transplant, Department of Medicine University of Florida, and North Florida\/South Georgia Veterans Health System Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Biomedical Informatics University of Florida College of Medicine Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Gainesville Florida"},{"name":"Division of Cardiovascular Medicine, Department of Medicine University of Florida College of Medicine Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.09.014"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2015.07.005"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_84"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121468"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.12.013"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1523-6"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00418-3"},{"issue":"36","key":"e_1_2_7_10_1","first-page":"1","article-title":"Resistant hypertension and chronic kidney disease: a dangerous liaison","volume":"18","author":"Wolley MJ","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.061"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05694"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000322923"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-88"},{"key":"e_1_2_7_15_1","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"CKD Kdigok","year":"2013","journal-title":"Kidney Int"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1584.2012.01283.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117703059"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-014-0525-x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2012.07.004"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2012.717478"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00258.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07821109"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.189141"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00550113"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft346"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000485"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.01.002"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-013-0009-4"},{"key":"e_1_2_7_30_1","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin\u2010angiotensin\u2010aldosterone system inhibitors","volume":"21","author":"Epstein M","year":"2015","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-012-0293-4"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18081682","article-title":"Sympathetic overactivity in chronic kidney disease: consequences and mechanisms","volume":"18","author":"Kaur J","year":"2017","journal-title":"Int J Mol Sci"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.157"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X675386"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-012-0332-8"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003166"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-017-0933-z"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06487"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08729"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001382"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.13429","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T05:32:40Z","timestamp":1694669560000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.13429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/jch.13429"],"URL":"https:\/\/doi.org\/10.1111\/jch.13429","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"2018-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}